NewsRx

Search our medical news database

Atrial Fibrillation

Cryotherapy company reports positive data at atrial fibrillation conference

Published in Biotech Business Week, February 13th, 2006

CryoCath Technologies, Inc., (CYT) a company focused on cryotherapy products to treat cardiovascular disease, announced that Dr. Douglas Packer, from Mayo Clinic, presented additional data from the feasibility stage of the Cryo System Trial Of Paroxysmal Atrial Fibrillation (STOP AF) investigational device exemption study using the company's proprietary Arctic Front catheter to treat atrial fibrillation (AF).

The data was presented at the annual International Boston Atrial Fibrillation Symposium.

Packer reported data on two sets of Arctic Front patient data. Firstly, he reviewed the 12-month data from the original 20-patient European trial which saw...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook